| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 08/15/2006 | US7091003 Polypeptides having phospholipase B activity and nucleic acids encoding same |
| 08/15/2006 | US7091002 Carboxypeptidases and nucleic acids encoding same |
| 08/15/2006 | US7091000 Bacterial strains which overproduce riboflavin and methods of use thereof |
| 08/15/2006 | US7090998 Transgenic proteobacterium comprising mutation in aerobic respiration control (ARC) for preparation and generation of glutamic acid and lysine for use in cosmetics, animal feeds and medicines |
| 08/15/2006 | US7090997 Diagnostic agent and test method for colon cancer using tannase as index |
| 08/15/2006 | US7090994 Methods of screening for introduction of DNA into a target cell |
| 08/15/2006 | US7090991 System for detection of a functional interaction between a compound and a cellular signal transduction component |
| 08/15/2006 | US7090989 Recombinant human SM-11044-binding receptor proteins exhibiting ligand-binding activities, and their uses |
| 08/15/2006 | US7090986 identifying compounds such as antibodies that compete with the binding of Saratin to collagen by determining the binding of said Saratin to collagen in the presence or absence of a competitor. |
| 08/15/2006 | US7090857 Polysaccharides and/or glycopeptides preparable from keratinophilic fungi and yeasts; vaccines, immunomodulators, and antiallergens; precipitation and separation of supernatant; treatment with mineral or organic acid |
| 08/15/2006 | US7090856 Anti-fouling exopolysaccharides isolated from cultures of Vibrio alginolyticus and Vibrio proteolyticus |
| 08/15/2006 | US7090850 Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/15/2006 | US7090849 Babesia canis vaccine |
| 08/15/2006 | US7090843 immunotherapy; fusion proteins; antitumor agents; for treatment and prevention of hodgkin's disease |
| 08/15/2006 | US7090840 Lactobacillus paracasei subsp. paracasei strain antibacterial against Helicobacter pylori and Escherichia coli 0157:h7 |
| 08/15/2006 | US7090838 Eliminating off-flavor in water and/or fish; cyanobacteria; reduction of chlorophyll; improved storage stability |
| 08/15/2006 | US7090836 Vector for expressing α-L-iduronidase and method of treating MPS I by stereotactic injection into the brain of a mammal |
| 08/10/2006 | WO2006084129A2 Genes of porphyromonas gingivalis w83 involved in invasion of human cells |
| 08/10/2006 | WO2006083995A1 Method for constructing eukaryotic cells having multiple genomic deletions and/or insertions |
| 08/10/2006 | WO2006083936A2 Anti-ephb2 antibodies and methods using same |
| 08/10/2006 | WO2006083410A2 Recombinant microorganisms for increased production of organic acids |
| 08/10/2006 | WO2006083315A2 Non-dividing donor cells for gene transfer |
| 08/10/2006 | WO2006082992A1 Method of constructing novel higher plant and mehtod of promoting the growth of higher plant |
| 08/10/2006 | WO2006082851A1 Mucin relating to epiglycanin |
| 08/10/2006 | WO2006082826A1 METHOD OF IDENTIFYING PURKINJE CELL TARGETING Corl2 GENE |
| 08/10/2006 | WO2006082328A2 Compositions comprising dehydrated micro-organisms, method for preparing same, and uses thereof |
| 08/10/2006 | WO2006082254A2 Microorganisms comprising enzymes expressed with low gamma-elimination activity |
| 08/10/2006 | WO2006082252A2 Method for the enzymatic production of alpha-ketobutyrate |
| 08/10/2006 | WO2006060126A3 Heterologous alpha amylase expression in aspergillus |
| 08/10/2006 | WO2006029632A3 Chimeric phage-derived particles, methods for their production and use |
| 08/10/2006 | WO2005116229A3 Methods for the preparation of para-hydroxycinnamic acid and cinnamic acid at alkaline ph |
| 08/10/2006 | WO2003074004A3 Method of producing antigens |
| 08/10/2006 | US20060179498 Reverse breeding |
| 08/10/2006 | US20060179496 Nucleic acid sequences differentially expressed in cancer tissue |
| 08/10/2006 | US20060178506 Amino acid modified polypeptides |
| 08/10/2006 | US20060178503 Antibody to an integrin heterodimer and/or a subunit thereof |
| 08/10/2006 | US20060177920 Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids |
| 08/10/2006 | US20060177919 Polypeptide having amidohydrolase activity capable of hydrolysing 3,3,3-trifluoro-2-hydroxy-2-methyl propionamide in form of the racemate or of an optically active isomer; obtainable from Klebsiella oxytoca, Pseudomonas, Rhodococcus opacus, Arthrobacter ramosus, Bacillus |
| 08/10/2006 | US20060177917 Process for the production of cellulolytic and hemicellulolytic enzymes using distillation residues from the ethanolic fermentation of enzymatic hydrolyzates of (ligno)cellulosic materials |
| 08/10/2006 | US20060177915 Method for the production of glycerol by recombinant organisms |
| 08/10/2006 | US20060177912 Nucleotide sequences which code for the dep34 gene |
| 08/10/2006 | US20060177907 Methods and materials for characterizing and modulating interaction between heregulin and HER3 |
| 08/10/2006 | US20060177905 UDP-glucosyltransferases |
| 08/10/2006 | US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 08/10/2006 | US20060177900 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof |
| 08/10/2006 | US20060177898 Methods for producing modified glycoproteins |
| 08/10/2006 | US20060177897 PR1550 polypeptides and nucleic acids encoding the same |
| 08/10/2006 | US20060177895 Promoters provide a sterically repressed promoter in which an additional lac operator site is inserted between the -10 and -35 elements, where it can interfere sterically with binding of RNA polymerase and thereby prevent the assembly of a poised transcriptional complex |
| 08/10/2006 | US20060177893 Method for producing dipeptides |
| 08/10/2006 | US20060177861 Novel compositions and methods in cancer associated with altered expression of MCM3AP |
| 08/10/2006 | US20060177835 A dual oligonucleotide hybridization assay combining the advantages of the direct detection assays (e.g., easy quantification and minimal risk of carry-over contamination) with the specificity provided by a dual oligonucleotide hybridization assay; site-specific nuclease cleavage by a variety of enzymes |
| 08/10/2006 | US20060177822 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid |
| 08/10/2006 | US20060177817 Nucleic acid having a sequence that is codon-optimized for high level expression in a yeast cell; proteins produced provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity |
| 08/10/2006 | US20060177543 Process for producing liquid formulation containing raw yeast and liquid formulation |
| 08/10/2006 | US20060177466 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/10/2006 | US20060177465 Polypeptide antigens of streptococcus pneumoniae pathogen useful as vaccine for prophylaxis, diagnostic or treatment of streptococcal infection |
| 08/10/2006 | US20060177464 Methods and compositions involving LcrV proteins |
| 08/10/2006 | US20060177463 Fusion polypeptide; includes a first polypeptide that is glycosylated by a alpha 1, 3/4 fucosyltransferase (FUT3), an alpha 1,2 fucosyltransferase (FUT2) and a beta 1,3 galactosyltransferase operably linked to a second polypeptide |
| 08/10/2006 | US20060177456 Apo-2 receptor antibodies |
| 08/10/2006 | US20060177428 Expression vector comprising nucleotide sequences coding endothelial growth factor for use in diagnosis, prevention and treatment of tumor disorders |
| 08/10/2006 | US20060177425 Method for producing working reagent and for biological prevention or control |
| 08/10/2006 | CA2595901A1 Axmi-018, axmi-020, and axmi-021, a family of delta-endotoxin genes and methods for their use |
| 08/10/2006 | CA2594636A1 Anti-ephb2 antibodies and methods using same |
| 08/10/2006 | CA2592449A1 Recombinant microorganisms for increased production of organic acids |
| 08/10/2006 | CA2508532A1 Method for stabilizing dormant organisms by mixing with a moisture free carrier |
| 08/09/2006 | EP1688499A1 Alcohol-aldehyd-dehydrogenases |
| 08/09/2006 | EP1688496A2 Regulation of human P2Y1-like G protein-coupled receptor |
| 08/09/2006 | EP1688494A1 Monkey npy y4 recepotr and method of evaluating compound |
| 08/09/2006 | EP1688490A1 Dose-dependent promoter originating in humans |
| 08/09/2006 | EP1688482A1 Method for producing L-amino acid using bacteria belonging to the genus Escherichia |
| 08/09/2006 | EP1688481A1 Bifidobacterium in the treatment of inflammatory disease |
| 08/09/2006 | EP1688480A2 NOVEL ACETOACETYL-CoA REDUCTASE AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1687431A2 Compositions and methods for screening pro-apoptotic compounds |
| 08/09/2006 | EP1687415A1 Method of isolating and culturing mesenchymal stem cell derived from cryopreserved umbilical cord blood |
| 08/09/2006 | EP1687414A1 Method of isolating and culturing mesenchymal stem cell derived from umbilical cord blood |
| 08/09/2006 | EP1687409A2 Culture medium for rapid detection of mycobacterial growth by color change |
| 08/09/2006 | EP1687408A1 Method for producing l-amino acid by fermentation |
| 08/09/2006 | EP1687401A2 Site-specific incorporation of redox active amino acids into proteins |
| 08/09/2006 | EP1687399A2 Modified luciferase |
| 08/09/2006 | EP1687324A2 Improved expression systems with sec-system secretion |
| 08/09/2006 | EP1686947A2 Method for the production of bioactive substances from the novel actinomycete taxon mar2 (marinophilus) |
| 08/09/2006 | EP1686852A2 Improved method of freezing with brine |
| 08/09/2006 | EP1456351B1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 08/09/2006 | EP1387693B1 Saponin inactivated mycoplasma vaccine |
| 08/09/2006 | EP1339853B1 Isolated luciferases and the use thereof |
| 08/09/2006 | EP1307481B1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 08/09/2006 | EP1204755B1 Process for the biological production of 1,3-propanediol |
| 08/09/2006 | EP1200604B1 Production of proteins |
| 08/09/2006 | EP1185631B1 Novel endo-beta-1,4-glucanases |
| 08/09/2006 | EP1165750B1 Diagnosis of whipple disease |
| 08/09/2006 | EP1160330B1 Substances wk-5344a and wk-5344b and process for producing the same |
| 08/09/2006 | EP1133319B1 Photosensitizer conjugates for targeting intracellular pathogens |
| 08/09/2006 | EP1069135B1 Proteins having immunomodulatory activity and remedies for immunological diseases |
| 08/09/2006 | EP0939763B1 Directed switch-mediated dna recombination |
| 08/09/2006 | EP0935656B1 Hedgehog interacting proteins and uses related thereto |
| 08/09/2006 | EP0920305B1 Identification of genes altered in multiple myeloma |
| 08/09/2006 | CN1816632A Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 08/09/2006 | CN1816631A Variants of beta-glucosidases |
| 08/09/2006 | CN1816630A Delta-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts |